A state Food and Drug Administration commissioner in India denied that the bio-availability of generic drugs is doubtful, in spite of claims to the contrary made by doctors and chemists. "Bio-availability" is a term used for the amount of a drug that reaches its target. "These are excuses to deny people their right to get medicines at rational prices," said Commissioner Mahesh Zagade, who urged the national government to require that physicians add a line to prescriptions noting that generic or other cheaper versions are available.

Full Story:
The Times of India

Related Summaries